ZEB1 and lung carcinoma: In the lung cancer microenvironment, TAMs can promote EMT in tumor cells by releasing TGF-β, which acts on signaling pathways such as the Smad/ZEB and C-jun/SMAD3 pathways, thereby increasing the metastatic potential and proliferation ability of tumors (82, 83).